...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Pulmonary Hypertension News

Je suis en accord avec toi growacet, it's nice when people take interest in RVX news. Nice!

 

Resverlogix recently completed the Phase 3 clinical study BETonMACE (NCT02586155), testing apabetalone on high-risk cardiovascular disease patients with type 2 diabetes mellitus and low levels of high-density lipoprotein.

But that statement is false. 

Cant wait for completion. Tick tock.

Share
New Message
Please login to post a reply